The January 1st deadline for completion of your hospital's IQCP is coming fast, along with a host of questions from those responsible for creating their plans. If IQCP is optional, what are the alternatives? Is an IQCP plan needed for every blood gas analyzer?
If you are responsible for all or part of your hospital's IQCP, these may be some of the questions you're facing now and over the next few short months. Fortunately, Dr. James Nichols, Vanderbilt University School of Medicine's Professor of Pathology, Microbiology, and Immunology will be addressing these and many others at Radiometer’s upcoming webinar: IQCP Demystified: Practical considerations for your blood gas analyzer.
During the 1-hour webinar, Dr. Nichols will address key questions you will need to consider when preparing your IQCP. In addition, Dr. Nichols will walk through some specific examples of different blood gas analyzers and illustrate how IQCP may apply to them.
IQCP is an important change to the regulatory landscape. This can appear to be a burden to many, particularly with the number of plans that may be required to adapt to the pre- and post-analytical process changes between departments and use cases. The webinar will also address some of the potential risks that should be considered when developing your IQCP for blood gas instruments.
This Webinar Will:
- Analyze the instances in which an IQCP is required for a blood gas analyzer
- Review the pre and post analytic considerations when developing an IQCP
- Discuss the process used to identify risk areas for blood gas testing
James H. Nichols, PhD, DABCC, FACB
Dr. Nichols is a Professor of Pathology, Microbiology, and Immunology and Medical Director of Clinical Chemistry at Vanderbilt University School of Medicine. Dr. Nichols received his B.A. in General Biology/Premedicine from Revelle College, University of California at San Diego. He went on to complete a Masters and Doctorate in Biochemistry from the University of Illinois, Urbana-Champaign. Jim was a fellow in the Postdoctoral Training Program in Clinical Chemistry at the Mayo Clinic, Rochester, MN. He is board certified in both Clinical Chemistry and Toxicological Chemistry by the American Board of Clinical Chemistry.
Dr. Nichols spent several years as Associate Director of Clinical Chemistry, Director of Point-of-Care Testing, and an Associate Professor of Pathology at Johns Hopkins Medical Institutions. Jim later served as Medical Director of Clinical Chemistry for Baystate Health in Springfield, MA and was a Professor of Pathology at Tufts University School of Medicine. Dr. Nichols’ research interests span evidence-based medicine, information management, laboratory automation, point-of-care testing and toxicology.
Who Should Attend?
- Point of care coordinators
- Respiratory therapists
- Quality/risk management
- Medical directors
- One PACE® credit-hour will be provided for this session
- This session is approved for 1 Florida CE credit. (Florida Board of Clinical Laboratory Personnel approved number: 50-12563)
- Application has been made to the American Association for Respiratory Care (AARC) for continuing education contact hours for respiratory therapists.